Posts

The Patient-Centered Outcomes Research Institute (PCORI) today announced the approval of funding awards totaling $225 million, which include $207 million to support 20 new patient-centered comparative clinical effectiveness research (CER) studies.

The Patient-Centered Outcomes Research Institute (PCORI) today announced funding awards totaling $80.5 million to support four new, ambitious patient-centered comparative clinical effectiveness research (CER) studies focused on both the health care and social factors that contribute to inequities in maternal morbidity and mortality.

The Patient-Centered Outcomes Research Institute (PCORI) today began inviting proposals for new studies and implementation projects through 11 funding opportunities, including the first focused specifically on PCORI Topic Themes. These PCORI Funding Announcements (PFAs) include up to $610 million for patient-centered comparative clinical effectiveness research (CER) studies that compare health care options to generate evidence that helps patients and those who care for them make better-informed choices.

The Patient-Centered Outcomes Research Institute (PCORI) today announced funding awards totaling $208 million to support 17 new comparative clinical effectiveness research (CER) studies, including four trials of particularly large scale and scope tackling complex questions. All the approved studies aim to fill evidence gaps and enhance health care decision making with a focus on a variety of high-burden concerns.

WASHINGTON, DC — The Patient-Centered Outcomes Research Institute (PCORI) today began inviting proposals for new studies and implementation projects through nine funding opportunities. These PCORI Funding Announcements (PFAs) include four…

WASHINGTON, DC — The Patient-Centered Outcomes Research Institute (PCORI) today announced funding awards totaling $123 million to support 15 new research studies. These studies aim to fill evidence gaps, enhance…

WASHINGTON, DC — The Patient-Centered Outcomes Research Institute (PCORI) has opened the application periods for nine funding opportunities that offer up to $308.5 million in total funding. The latest PCORI…

Editor's Note (February 27, 2023) These eight Topic Themes join four that are ongoing—preventing maternal morbidity and mortality, improving outcomes for people with intellectual or developmental disabilities, addressing COVID-19, and…

More than 100,000 people in the United States have sickle cell disease —a group of inherited red blood cell disorders that affect blood flow and the body’s use of oxygen…

WASHINGTON, DC — The Patient-Centered Outcomes Research Institute (PCORI) has approved funding awards totaling $258 million to support 26 new research studies. These studies aim to fill evidence gaps and…

Delivering on its commitment to develop an extensive pipeline of funding opportunities made earlier this year, PCORI opens its third funding cycle on September 7. The funding cycle includes nine…

Migraine headache is a disabling condition that affects one in six Americans. Making sense of research results for the many treatments available for migraine is complicated. To help patients and…

More than a dozen topics ranging from healthy aging to prevention of drug addiction among adolescents and from telehealth to addressing bias, racism and discrimination throughout the health care continuum will be the focus of efforts to develop future research funding opportunities from the Patient-Centered Outcomes Research Institute (PCORI) following approval at today’s PCORI Board of Governors meeting.

Multiple sclerosis is an often disabling neurological condition that affects about 400,000 people in the United States. People with MS can develop a wide variety of symptoms, including vision problems…

In 1986, I began experiencing bouts of numbness, fatigue, and lack of coordination on my left side. Those symptoms launched my 13-year journey toward a diagnosis of multiple sclerosis, or…

Although new results from an ongoing PCORI-funded study into whether some patients with multiple sclerosis (MS) can safely stop taking certain kinds of medications as they age weren’t conclusive in…

Many people with chronic migraines use medication more often than recommended. This overuse can have the undesired effect of more migraines and headaches and other serious side effects. The PCORI-funded…

The latest Emerging Health Care Innovation Brief highlights two recent actions by the US Food and Drug Administration (FDA): The approval of the first treatment for adults and children with…